References
- D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q. J. Med. 1987; 645: 709–727
- D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am. J. Kidney Dis. 2000; 36: 227–237, [PUBMED], [INFOTRIEVE]
- Schmekel B., Svalander C., Bucht H., Westberg N. G. Mesangial IgA glomerulonephritis in adults and histopathological observations. Acta Med. Scand. 1981; 210: 363–372, [PUBMED], [INFOTRIEVE]
- Habib R., Niaudet P., Levey M. Schönlein–Henoch purpura nephritis and IgA nephropathy. Renal Pathology with Clinical and Functional Correlations2nd Ed., C. C. Tisher, B. M. Brenner. JB Lippincott, Philadelphia 1994; 472–523
- Alexopoulos E., Seron D., Hartley R. B., et al. The role of interstitial infiltrates in IgA nephropathy. A study with monoclonal antibodies. Nephrol. Dial. Transplant. 1989; 4: 187–195, [PUBMED], [INFOTRIEVE]
- Donadio J. V., Jr. Omega‐3 polyunsaturated fatty acids: a potential new treatment of immune renal disease. Mayo Clin. Proc. 1991; 66: 1018–1028, [PUBMED], [INFOTRIEVE]
- Hamazaki T., Tateno S., Shishido H. Eicosapentaenoic acid and IgA nephropathy. Lancet 1984; 1: 1017–1018, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cheng I. K.P., Chan P. C.K., Chan M. K. The effect of fish‐oil dietary supplement on the progression of mesangial IgA glomerulonephritis. Nephrol. Dial. Transplant. 1990; 5: 241–246, [PUBMED], [INFOTRIEVE]
- Bennett W. M., Walker R. G., Kincaid‐Smith P. Treatment of IgA nephropathy with eicosapentaenoic acid (EPA): a two‐year prospective trial. Clin. Nephrol. 1989; 31: 128–131, [PUBMED], [INFOTRIEVE]
- Pettersson E. E., Rekola S., Berglund D., et al. Treatment of IgA nephropathy with omega‐3 polyunsaturated fatty acids: A prospective, double‐blind, randomized study. Clin. Nephrol. 1994; 41: 183–190, [PUBMED], [INFOTRIEVE], [CSA]
- Donadio J. V., Jr, Bergstralh E. J., Offord K. P., et al. A controlled trial of fish oil in IgA nephropathy. N. Engl. J. Med. 1994; 331: 1194–1199, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Donadio J. V., Jr, Grande J. P., Bergstralh E. J., et al. The long‐term outcome of patients with IgA nephropathy treated with fish‐oil in a controlled trial. J. Am. Soc. Nephrol. 1999; 10: 1772–1777, [PUBMED], [INFOTRIEVE], [CSA]
- Donadio J. V., Jr, Larson T. S., Bergstralh E. J., et al. A randomized trial of high‐dose compared to low‐dose omega‐3 fatty acids in severe IgA nephropathy. J. Am. Soc. Nephrol. 2001; 12: 791–799, [PUBMED], [INFOTRIEVE], [CSA]
- Andreoli S. P., Yum N. M., Bergstein J. M. IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA. Am. J. Nephrol. 1986; 6: 28–33, [PUBMED], [INFOTRIEVE], [CSA]
- Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41, [PUBMED], [INFOTRIEVE]
- The GISEN Group (Gruppo Italiano di studi Epidemiologici in Nephrologia). Randomized, placebo‐controlled trial of effects of ramipril on decline in glomerular filtration rate and risk of terminal renal failure, in proteinuric, non‐diabetic nephropathy. Lancet 1997; 349: 1857–1863
- De Caterina R., Caprioli R., Giannessi D., et al. n‐3 Fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int. 1993; 44: 843–850, [PUBMED], [INFOTRIEVE]
- Hall A. V., Parbtani A., Clark W. F., et al. Omega‐3 fatty acids supplementation in primary nephrotic syndrome: effects on plasma lipids and coagulopathy. J. Am. Soc. Nephrol. 1992; 3: 1321–1329, [PUBMED], [INFOTRIEVE]
- Cartwright I. J., Pockley A. G., Galloway J. H., et al. The effects of dietary omega‐3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis 1985; 55: 267–281, [PUBMED], [INFOTRIEVE]
- Fischer S., Weber P. C. Thromboxane A3 (TxA3) is formed in human platelets after dietary eicosapentaenoic acid (C20: 5ω3). Biochem. Biophys. Res. Commun. 1983; 116: 1091–1099, [PUBMED], [INFOTRIEVE]
- Radford F. M., Jr, Donadio J. V., Jr, Bergstralh E. J., Grande J. P. Predicting renal outcome in IgA nephropathy. J. Am. Soc. Nephrol. 1997; 8: 199–207, [PUBMED], [INFOTRIEVE], [CSA]
- Beukof J. R., Kardaun O., Schaafsma W., et al. Toward individual prognosis of IgA nephropathy. Clin. Invest. 1986; 29: 549–556
- Rekola S., Bergstrand A., Bucht H. IgA nephropathy: a retrospective evaluation of prognostic indices in 176 patients. Scand. J. Urol. Nephrol. 1989; 23: 37–50, [PUBMED], [INFOTRIEVE]